The MarketWatch News Department was not involved in the creation of this content. New patent-pending technology helps creators reduce risk and make smarter creative decisions before content goes live.

Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.

ATLANTA, GEORGIA / ACCESS Newswire / December 3, 2025 / OMP is helping McCormick & Co., the global leader in flavor, with an AI-driven and autonomous operational planning initiative. This partnership ...

Through its partnership with OMP, McCormick is implementing autonomous, decision-centric planning powered by agentic AI to transform how production and inventory are managed. The solution enables ...

ATLANTA, GEORGIA / ACCESS Newswire / December 3, 2025 / OMP is helping McCormick & Co., the global leader in flavor, with an AI-driven and autonomous operational planning initiative. This partnership ...

The content on this page was provided by an independent third party and syndicated by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of ...